TCT 1708: Kissing DCBs in NSTEMI: Sirolimus-Coated Balloon Use With Selution™ for ISR and Stent Thrombosis in a Bifurcation Lesion Receive the the latest news, research, and presentations from major ...

Patients are at increased risk for recurrent ischemic events after an acute coronary syndrome event. Milvexian, an oral factor XIa inhibitor, may reduce the risk of major adverse clinical events with ...

Noninferiority was not demonstrated for death and ischemic events between P2Y12 inhibitor monotherapy and dual antiplatelet therapy (DAPT) given for 12 months after stenting in patients with acute ...

In patients with acute or chronic coronary syndrome who underwent invasive management, prasugrel was associated with the most favorable balance between efficacy and safety, with lower odds of major ...

Acute coronary syndrome (defined here as unstable angina and non-ST elevation myocardial infarction [MI]) is characterized by episodes of chest pain at rest or with minimal exertion that are ...

Remote Cardiac Monitoring After Acute Coronary Syndrome (HEART-CHECK study): Hybrid effectiveness-implementation study evaluating the HeartBeam System for early detection and triage of acute coronary ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

CVD, the HEART-CHECK study will evaluate the HeartBeam System for early detection and triage of cardiac events in high-risk patients recently discharged after an acute coronary syndrome (ACS), a group ...

A widely used type of heart medicine may be linked to a higher risk of heart failure in some women after a serious heart ...